News and information about basic science that may lead researchers to develop a cure for HIV – studies of the latent viral reservoir, shock and kill approaches, gene therapies, immune modulators therapeutic vaccines, broadly neutralizing antibodies and so on.

The search for a cure: latest news

The search for a cure resources

The search for a cure features

The search for a cure news from aidsmap

More news

The search for a cure news selected from other sources

  • Proof-of-concept HIV immunotherapy study passes Phase 1 safety trial

    Preliminary results from a phase I clinical trial have demonstrated the safety and tolerability of a cell therapy involving the ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals previously treated with antiretroviral therapy (ART). The study appears September 21st in the journal Molecular Therapy.

    24 September 2018 | Science Daily
  • Investigators Uncover Details About A Rare Group of HIV Patients

    A pair of new studies is shedding light on a rare, but scientifically important, group of people with HIV who are able to maintain viral control even after stopping antiretroviral therapy. Clues about this ability may help improve antiretroviral therapy, which currently most patients with HIV must receive for life.

    24 September 2018 | MD Magazine
  • Largest study of 'post-treatment controllers' reveals clues about HIV remission

    Much remains unknown about this unique group of individuals, known as HIV post-treatment controllers, including how rare this ability is. Two new studies—including the largest study of post-treatment controllers to date—explore the characteristics of this group as well as the biological mechanisms that may help explain this unique ability.

    14 September 2018 | Medical Xpress
  • Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research

    Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research. Published in the prestigious journal Proceedings of the National Academy of Sciences (PNAS), the BC Centre for Excellence in HIV/AIDS' first major scientific contribution to the area of HIV cure research confirms that dormant HIV strains can persist in the body for decades.

    06 September 2018 | Eurekalert Inf Dis
  • AIDS 2018 HIV cure research highlights

    The 22nd International AIDS Conference took place in Amsterdam from July 23–27, 2018. Here, we summarize key highlights on HIV cure-related research from the conference.

    30 August 2018 | Positively Aware
  • Towards an HIV cure with optimism

    ‘Freedom!’ ‘hope’ ‘the ability to live life to the fullest’ were the top responses to the question ‘what would a HIV cure mean to you?’ when I asked community participants at AIDS 2018 in Amsterdam. Engaging in HIV cure efforts for many of us means growing our shared freedom, hope and love. As a person who shares this community sentiment, what follows is an optimist’s gaze of progress towards a HIV cure.

    23 August 2018 | HIV Cure
  • ‘It’s sobering’: A once-exciting HIV cure strategy fails its test in people

    When Science published a monkey study nearly 2 years ago that showed an anti-inflammatory antibody effectively cured monkeys intentionally infected with the simian form of the AIDS virus, the dramatic results turned many heads. But some skeptical researchers thought the data looked too good to be true and predicted the intervention wouldn’t work on HIV in humans. They were right.

    30 July 2018 | Science
  • Fauci: HIV remission free of antiretroviral therapy is a feasible goal

    Long-lasting control of HIV infection without antiretroviral therapy (ART) is a feasible goal that deserves vigorous pursuit, Anthony S. Fauci, M.D., will assert during a lecture on Wednesday, July 25 at the 22nd International AIDS Conference (AIDS 2018) in Amsterdam.

    25 July 2018 | National Institutes of Health
  • Study indicates potential breakthrough HIV drug

    French biotech Abivax announces results of three month course of rev gene disruptor drug ABX464. Reductions in viral DNA seen in 50%. See http://www.aidsmap.com/ABX464-reduces-HIV-reservoir-but-doesnt-delay-viral-rebound/page/3184750/ for earlier study.

    05 July 2018 | Pharmaphorum
  • What’s the fuss about a functional cure?

    A recent study from researchers in Hong Kong has got the world’s media talking about a functional cure for HIV. A quick search for the terms ‘HIV, functional cure, Hong Kong’ yields a long list of articles and videos from around the world. Twitter has also been going crazy. Read on to find out what the researchers did, what they found, and more importantly, what this means for people living with HIV.

    22 June 2018 | HIV Cure
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.